title: Severe cutaneous toxicity related to Eltrombopag.
authors.affiliation: Haematology, University Hospital Basel, Basel, Switzerland.
authors.forename: Sara C
authors.initials: SC
authors.lastname: Meyer
authors.forename: Alicia
authors.initials: A
authors.lastname: Rovó
authors.forename: Dimitrios A
authors.initials: DA
authors.lastname: Tsakiris
authors.forename: Kathrin
authors.initials: K
authors.lastname: Scherer
authors.forename: André
authors.initials: A
authors.lastname: Tichelli
authors.forename: Andreas
authors.initials: A
authors.lastname: Holbro
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001565:Benzoates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000188:drug therapy; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D012871:Skin Diseases / Q000139:chemically induced*
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; C520809:eltrombopag